Skip to Content
PR Newswire

Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference

Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference

Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference

PR Newswire

MARLBOROUGH, Mass., May 24, 2021

MARLBOROUGH, Mass., May 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 37th Annual Strategic Decisions Conference on Friday, June 4, 2021.

Mike Mahoney, chairman and chief executive officer, Susie Lisa, vice president, Investor Relations, and Lauren Tengler, director, Investor Relations will participate in a virtual 45-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EDT.  A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media:

Investors:

Katie Schur

Susie Lisa, CFA

508-683-5574 (office)

508-683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

Katie.Schur@bsci.com

BSXInvestorRelations@bsci.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-bernsteins-37th-annual-strategic-decisions-conference-301297359.html

SOURCE Boston Scientific Corporation

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.